Literature DB >> 33788191

Hypercapnic Respiratory Failure-Driven Skeletal Muscle Dysfunction: It Is Time for Animal Model-Based Mechanistic Research.

Ariel Jaitovich1,2.   

Abstract

Dysfunction of locomotor muscles is frequent in chronic pulmonary diseases and strongly associated with worse outcomes including higher mortality. Although these associations have been corroborated over the last decades, there is poor mechanistic understanding of the process, in part due to the lack of adequate animal models to investigate this process. Most of the mechanistic research has so far been accomplished using relevant individual stimuli such as low oxygen or high CO2 delivered to otherwise healthy animals as surrogates of the phenomena occurring in the clinical setting. This review advocates for the development of a syndromic model in which skeletal muscle dysfunction is investigated as a comorbidity of a well-validated pulmonary disease model, which could potentially allow discovering meaningful mechanisms and pathways and lead to more substantial progress to treat this devastating condition.

Entities:  

Keywords:  AMPK; Muscle atrophy; Myogenesis; Protein anabolism; Protein catabolism; Respiratory failure

Mesh:

Year:  2021        PMID: 33788191      PMCID: PMC9131243          DOI: 10.1007/978-3-030-63046-1_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  76 in total

1.  PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY.

Authors:  S ERIKSSON
Journal:  Acta Med Scand       Date:  1964-02

Review 2.  Satellite cells and the muscle stem cell niche.

Authors:  Hang Yin; Feodor Price; Michael A Rudnicki
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

3.  High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1).

Authors:  Ariel Jaitovich; Martín Angulo; Emilia Lecuona; Laura A Dada; Lynn C Welch; Yuan Cheng; Galina Gusarova; Ermelinda Ceco; Chang Liu; Masahiko Shigemura; Esther Barreiro; Cam Patterson; Gustavo A Nader; Jacob I Sznajder
Journal:  J Biol Chem       Date:  2015-02-17       Impact factor: 5.157

4.  Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.

Authors:  Ariel Jaitovich; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

5.  Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema.

Authors:  J D'Armiento; S S Dalal; Y Okada; R A Berg; K Chada
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

6.  Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

Authors:  Pamela J Plant; Dina Brooks; Marie Faughnan; Tanya Bayley; James Bain; Lianne Singer; Judy Correa; Dawn Pearce; Matthew Binnie; Jane Batt
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

Review 7.  Role of autophagy in COPD skeletal muscle dysfunction.

Authors:  Sabah N A Hussain; Marco Sandri
Journal:  J Appl Physiol (1985)       Date:  2012-10-18

8.  Skeletal muscle mass and mortality - but what about functional outcome?

Authors:  Zudin A Puthucheary; Nicholas Hart
Journal:  Crit Care       Date:  2014-02-17       Impact factor: 9.097

9.  Editing out five Serpina1 paralogs to create a mouse model of genetic emphysema.

Authors:  Florie Borel; Huaming Sun; Marina Zieger; Andrew Cox; Brynn Cardozo; Weiying Li; Gabriella Oliveira; Airiel Davis; Alisha Gruntman; Terence R Flotte; Michael H Brodsky; Andrew M Hoffman; Mai K Elmallah; Christian Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-16       Impact factor: 11.205

10.  Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD).

Authors:  P A Leermakers; A M W J Schols; A E M Kneppers; M C J M Kelders; C C de Theije; M Lainscak; H R Gosker
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.